Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D M Vail

Showing results (11-20 of 78) with videos related to

Pageof 8
Sort By:
Veterinary and Comparative Oncology|January 31, 2009
Serum vascular endothelial growth factor concentrations and postsurgical outcome in dogs with osteosarcomaD H Thamm, M G O'Brien, D M Vail
American Journal of Veterinary Research|March 1, 1995
Differential cell analysis and phenotypic subtyping of lymphocytes in bronchoalveolar lavage fluid from clinically normal dogsD M Vail, P A Mahler, S A Soergel
Journal of Veterinary Internal Medicine|March 1, 1994
Thyroid hormone concentrations in dogs with chronic weight loss, with special reference to cancer cachexiaD M Vail, D L Panciera, G K Ogilvie
Veterinary and Comparative Oncology|January 13, 2012
Phase II clinical evaluation of lomustine chemotherapy for feline vaccine-associated sarcomaC F Saba, D M Vail, D H Thamm
Veterinary and Comparative Oncology|January 13, 2012
Safety evaluation of combination toceranib phosphate (Palladia®) and piroxicam in tumour-bearing dogs (excluding mast cell tumours): a phase I dose-finding studyE Chon, L McCartan, L N Kubicek, et al.
Journal of Veterinary Internal Medicine|May 28, 2011
Intravenous administration of docetaxel to cats with cancerK B Shiu, L McCartan, L Kubicek, et al.
Veterinary and Comparative Oncology|April 17, 2014
Safety evaluation of combination CCNU and continuous toceranib phosphate (Palladia(®) ) in tumour-bearing dogs: a phase I dose-finding studyX Pan, K Tsimbas, I D Kurzman, et al.
Veterinary and Comparative Oncology|January 31, 2009
Dose-escalating vinblastine for the treatment of canine mast cell tumourK R Vickery, H Wilson, D M Vail, et al.
Cancer Biotherapy & Radiopharmaceuticals|June 13, 2000
In vitro and in vivo enhancement of canine pulmonary alveolar macrophage cytotoxic activity against canine osteosarcoma cellsI D Kurzman, F Shi, D M Vail, et al.
Journal of Veterinary Internal Medicine|September 1, 1990
Exacerbation of hyperlactatemia by infusion of lactated Ringer's solution in dogs with lymphomaD M Vail, G K Ogilvie, M J Fettman, et al.
Pageof 8

Showing results (11-20 of 78) with videos related to

Sort By:
Pageof 8
Veterinary and Comparative Oncology|January 31, 2009
Serum vascular endothelial growth factor concentrations and postsurgical outcome in dogs with osteosarcomaD H Thamm, M G O'Brien, D M Vail
American Journal of Veterinary Research|March 1, 1995
Differential cell analysis and phenotypic subtyping of lymphocytes in bronchoalveolar lavage fluid from clinically normal dogsD M Vail, P A Mahler, S A Soergel
Journal of Veterinary Internal Medicine|March 1, 1994
Thyroid hormone concentrations in dogs with chronic weight loss, with special reference to cancer cachexiaD M Vail, D L Panciera, G K Ogilvie
Veterinary and Comparative Oncology|January 13, 2012
Phase II clinical evaluation of lomustine chemotherapy for feline vaccine-associated sarcomaC F Saba, D M Vail, D H Thamm
Veterinary and Comparative Oncology|January 13, 2012
Safety evaluation of combination toceranib phosphate (Palladia®) and piroxicam in tumour-bearing dogs (excluding mast cell tumours): a phase I dose-finding studyE Chon, L McCartan, L N Kubicek, et al.
Journal of Veterinary Internal Medicine|May 28, 2011
Intravenous administration of docetaxel to cats with cancerK B Shiu, L McCartan, L Kubicek, et al.
Veterinary and Comparative Oncology|April 17, 2014
Safety evaluation of combination CCNU and continuous toceranib phosphate (Palladia(®) ) in tumour-bearing dogs: a phase I dose-finding studyX Pan, K Tsimbas, I D Kurzman, et al.
Veterinary and Comparative Oncology|January 31, 2009
Dose-escalating vinblastine for the treatment of canine mast cell tumourK R Vickery, H Wilson, D M Vail, et al.
Cancer Biotherapy & Radiopharmaceuticals|June 13, 2000
In vitro and in vivo enhancement of canine pulmonary alveolar macrophage cytotoxic activity against canine osteosarcoma cellsI D Kurzman, F Shi, D M Vail, et al.
Journal of Veterinary Internal Medicine|September 1, 1990
Exacerbation of hyperlactatemia by infusion of lactated Ringer's solution in dogs with lymphomaD M Vail, G K Ogilvie, M J Fettman, et al.
Pageof 8